Aronora CEO Named National Academy of Inventors Fellow
Dec 8, 2022
PORTLAND, Ore. - December 8, 2022 - (Newswire.com)
Erik Tucker, Ph.D., joins an elite group of inventors with his election to the National Academy of Inventors. Dr. Tucker's research into blood clotting diseases has launched two entirely new classes of blood thinners and clot busters that don't appear to have negative bleeding side effects.
"I am truly honored to be elected as a Fellow of the National Academy of Inventors, and proud to join an exceptional group of distinguished Fellows worldwide," said Tucker. "It's also incredibly exciting to see my scientific research being translated into revolutionary new medicines with the potential to help the millions of people who suffer from blood clots."
Dr. Tucker is an inventor on more than 90 U.S. and international patents, stemming from his investigations into the fundamental aspects of blood coagulation. As a graduate student at Oregon Health & Science University (OHSU), Tucker discovered ways to inhibit blood coagulation without triggering the negative bleeding side effects common with the currently approved blood thinners. These new therapeutics are designed to work by targeting thrombosis without disabling hemostasis. Tucker and his colleagues patented the research and after graduating, he co-founded the biotech company Aronora to translate these discoveries into the next generation of blood thinners and clot busters.
Blood clots that result in heart attack and stroke are the leading cause of death in the world, but despite its prevalence, research into blood clotting therapeutics has languished. One of the most widely prescribed blood thinners, heparin, was approved by the FDA in 1939, and the standard-of-care clot buster tPA was initially FDA-approved in 1987. The biggest problem is that all currently approved drugs can cause serious bleeding. Tucker aims to change the medical outcome for those suffering from blood clotting diseases with his new drug candidates.
"As a graduate student, I tested many FDA-approved drugs in our disease models, and was stunned to discover that our therapeutic strategies worked better and appeared safer than everything else we tested. I knew we had to develop these promising technologies and save people's lives." Aronora currently has two drug candidates, Gruticibart (AB023) and E-WE thrombin (AB002), in mid-stage clinical testing.
Erik Tucker received his B.S. from the University of Oregon and Ph.D. in Biomedical Engineering from OHSU. In addition to being CEO of Aronora, Inc., Tucker is an assistant professor of Biomedical Engineering within OHSU's School of Medicine, and is an affiliate member of OHSU Knight Cancer Institute's Center for Experimental Therapeutics.
The National Academy of Inventors Fellows Program recognizes inventors who have demonstrated prolific innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. Election as an NAI Fellow is the highest professional distinction accorded to academic inventors. The NAI Fellow program has 1,567 Fellows worldwide, and collectively, the Fellows hold more than 58,000 issued U.S. patents, which have generated over 13,000 licensed technologies, 3,200 companies and created more than one million jobs. In addition, over $3 trillion in revenue has been generated based on NAI Fellow discoveries. Among all NAI Fellows, there are 642 members of the National Academies of Science, Engineering and Medicine; 63 recipients of the U.S. National Medal of Technology and Innovation and U.S. National Medal of Science; and 45 Nobel Laureates. Dr. Tucker will be officially inducted at the NAI annual meeting in June 2023.
Contact Information:
Norah Verbout
Director of Strategic Partnerships
[email protected]
(503) 530-6842
Press Release Service by Newswire.com
Original Source: Aronora CEO Named National Academy of Inventors Fellow
More News
'Nightmare' for taxi drivers as fuel prices soar
Volunteer blood bike charity Freewheelers workers said they are also facing tough choices.
Paramount Settles States’ Lawsuit, Clearing Way for Warner Bros. Merger
By resolving a lawsuit filed by a group of states, the media mogul David Ellison removed the last major hurdle he faced in buying Warner Bros. Discovery.
Vet prescription fees capped under rule changes
Vets must also tell clients if cheaper medicine is available online as part of the rule updates which surgeries have the coming months to bring in.
Rising fuel prices 'cost tow truck business £10k'
A business says fuel duty will need to be cut by 30p to 50p per litre to help.
Soaring fuel costs hit small businesses
It comes as fuel prices reach their highest since 2022, driven by conflict in the Middle East.
Winter support planned for vulnerable residents
People could be eligible for awards of between £150 to £250, depending on their circumstances.
'How are we expected to pay for it?': Drivers' fears as fuel prices soar
Drivers and firms in the West Midlands say rising prices are hitting budgets and forcing cutbacks.
China’s Continued Control of Rare Earths Looms Over Trump-Xi Meeting
Manufacturers are struggling with constrained supplies as U.S. and Chinese officials negotiate over export restrictions with consequences for global industry.
Canadian province sues OpenAI over Tumbler Ridge school shooting
British Columbia has accused the company of failing to report the shooter's troubling interactions with ChatGPT to law enforcement.
Flights at major US airports delayed after cable cut by construction workers
The cable had been repaired and airports are resuming normal operations, the US transportation secretary says.
Trump and Xi Meet Amid an Uneasy U.S.-China Trade Truce
Beyond warm meetings between their leaders, the countries are engaging in tit-for-tat measures that call into question the stability of their arrangement.
I couldn't cook when I left home – but these easy £2.50 recipes became my go-to
Former culinary-challenged students share four low cost meals they think everyone can master.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.